PetMed Express, Inc. (PETS) Financial Ratios
27 years of historical data (2000–2026) · Healthcare · Medical - Pharmaceuticals
EV/EBITDA
↓
N/A
—
5yr avg: 127.38
30Y Low5.9·High26.4
P/FCF
↓
N/A
—
5yr avg: 23.01
30Y Low10.5·High45.2
P/B Ratio
↓
1.27
↓-39% vs avg
5yr avg: 2.07
30Y Low1.0·High18.6
ROE
↓
-100.4%
↑-425% vs avg
5yr avg: -19.1%
30Y Low-237%·High91%
Debt/EBITDA
↑
N/A
—
5yr avg: 5.25
30Y Low0.0·High15.5
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PETS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
PetMed Express, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $37M | $48M | $86M | $98M | $330M | $525M | $708M | $577M | $467M | $853M | $410M |
| Enterprise Value | $17M | $27M | $33M | $44M | $227M | $414M | $589M | $473M | $366M | $775M | $352M |
| P/E Ratio → | -0.64 | — | — | — | 64.96 | 24.81 | 23.14 | 22.31 | 12.38 | 22.94 | 17.21 |
| P/S Ratio | 0.21 | 0.27 | 0.38 | 0.36 | 1.29 | 1.92 | 2.33 | 2.03 | 1.65 | 3.12 | 1.65 |
| P/B Ratio | 1.27 | 1.65 | 1.01 | 1.01 | 3.00 | 3.69 | 5.01 | 4.44 | 3.47 | 7.37 | 4.40 |
| P/FCF | — | — | — | — | 14.65 | 31.36 | 18.80 | 15.80 | 10.49 | 23.26 | 11.21 |
| P/OCF | — | — | 18.29 | 22.63 | 11.88 | 28.39 | 17.66 | 14.86 | 10.34 | 22.82 | 8.69 |
P/E links to full P/E history page with 30-year chart
PETS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.15 | 0.14 | 0.16 | 0.89 | 1.51 | 1.94 | 1.67 | 1.29 | 2.83 | 1.41 |
| EV / EBITDA | — | — | 5.91 | 466.54 | 22.50 | 14.56 | 17.87 | 14.25 | 7.57 | 14.29 | 9.05 |
| EV / EBIT | — | — | — | — | 30.52 | 15.30 | 19.29 | 13.97 | 7.46 | 14.41 | 9.27 |
| EV / FCF | — | — | — | — | 10.08 | 24.73 | 15.65 | 12.96 | 8.23 | 21.13 | 9.61 |
PETS Profitability
Margins and return-on-capital ratios measuring operating efficiency
PetMed Express, Inc. earns an operating margin of -17.5%. Operating margins have compressed from -2.5% to -17.5% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -100.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.1% | 28.1% | 30.5% | 28.4% | 27.7% | 27.6% | 27.8% | 28.6% | 33.6% | 35.7% | 31.8% |
| Operating Margin | -17.5% | -17.5% | -0.7% | -2.5% | 2.6% | 9.4% | 10.1% | 10.9% | 16.3% | 19.0% | 15.0% |
| Net Profit Margin | -32.0% | -32.0% | -2.8% | -2.7% | 2.0% | 7.7% | 7.9% | 9.1% | 13.3% | 13.6% | 9.6% |
Return on Capital
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -100.4% | -100.4% | -6.9% | -7.2% | 4.1% | 14.9% | 17.6% | 19.5% | 30.1% | 35.7% | 27.0% |
| ROA | -49.8% | -49.8% | -3.9% | -4.4% | 3.0% | 11.6% | 14.0% | 16.7% | 26.1% | 30.1% | 23.5% |
| ROIC | -119.4% | -119.4% | -3.1% | -21.0% | 25.9% | 71.9% | 93.8% | 76.9% | 96.3% | 108.0% | 70.1% |
| ROCE | -54.6% | -54.6% | -1.7% | -6.6% | 5.1% | 18.0% | 22.3% | 23.2% | 36.6% | 49.4% | 42.2% |
PETS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $21M exceeds total debt of $535000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | — | — | — | — | — | — |
| Debt / EBITDA | — | — | 0.18 | 15.47 | 0.10 | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.72 | -0.63 | -0.56 | -0.94 | -0.78 | -0.84 | -0.80 | -0.75 | -0.67 | -0.63 |
| Net Debt / EBITDA | — | — | -9.75 | -572.79 | -10.21 | -3.90 | -3.60 | -3.12 | -2.08 | -1.44 | -1.51 |
| Debt / FCF | — | — | — | — | -4.57 | -6.63 | -3.15 | -2.84 | -2.26 | -2.12 | -1.60 |
| Interest Coverage | — | — | — | — | — | — | 25.23 | — | — | — | — |
Net cash position: cash ($21M) exceeds total debt ($535000)
PETS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.84x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 1.30x to 0.84x over the past 3 years.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | 0.84 | 1.26 | 1.30 | 2.27 | 4.55 | 3.59 | 5.30 | 6.79 | 5.81 | 4.46 |
| Quick Ratio | 0.58 | 0.58 | 1.00 | 0.90 | 1.94 | 3.57 | 2.82 | 4.57 | 5.64 | 4.52 | 3.35 |
| Cash Ratio | 0.41 | 0.41 | 0.87 | 0.77 | 1.81 | 3.35 | 2.64 | 4.26 | 5.40 | 4.30 | 3.20 |
| Asset Turnover | — | 2.20 | 1.53 | 1.61 | 1.51 | 1.55 | 1.62 | 1.83 | 1.84 | 2.03 | 2.21 |
| Inventory Turnover | 9.47 | 9.47 | 9.74 | 6.88 | 9.77 | 6.10 | 6.37 | 11.34 | 8.80 | 7.54 | 8.40 |
| Days Sales Outstanding | — | 3.89 | 3.73 | 4.37 | 2.48 | 2.55 | 3.11 | 4.94 | 3.27 | 3.06 | 2.65 |
PETS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
PetMed Express, Inc. returns 0.1% to shareholders annually primarily through dividends.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.1% | 0.0% | 0.2% | 12.7% | 7.4% | 4.6% | 3.2% | 3.8% | 4.7% | 2.0% | 3.8% |
| Payout Ratio | — | — | — | — | 477.4% | 115.6% | 94.8% | 84.3% | 58.1% | 46.9% | 65.1% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 1.5% | 4.0% | 4.3% | 4.5% | 8.1% | 4.4% | 5.8% |
| FCF Yield | — | — | — | — | 6.8% | 3.2% | 5.3% | 6.3% | 9.5% | 4.3% | 8.9% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.1% | 0.0% | 0.2% | 12.7% | 7.4% | 4.6% | 3.2% | 5.8% | 4.7% | 2.0% | 3.8% |
| Shares Outstanding | — | $21M | $21M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M |
Peer Comparison
Compare PETS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PETSYou | $37M | -0.6 | — | — | 28.1% | -17.5% | -100.4% | -119.4% | — |
 CHWY | $8B | 35.0 | 18.9 | 13.4 | 29.8% | 2.0% | 58.7% | 105.2% | 1.5 |
 WOOF | $748M | 82.6 | 10.6 | 4.0 | 38.7% | 2.0% | 0.8% | 2.4% | 9.0 |
 FRPT | $3B | 20.8 | 16.4 | 218.4 | 38.6% | 8.6% | 12.3% | 5.3% | 3.1 |
 HIMS | $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
 TDOC | $1B | -7.1 | 17.1 | 5.1 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 GOCO | $9M | -0.0 | — | — | 73.4% | -42.3% | -113.5% | -14.5% | — |
 RXRX | $1B | -2.2 | — | — | -62.0% | -867.9% | -59.5% | -95.8% | — |
 ZTS | $33B | 13.1 | 9.8 | 14.5 | 70.5% | 38.0% | 66.0% | 26.9% | 2.3 |
 ELAN | $12B | -51.5 | 16.7 | 42.6 | 43.5% | 5.3% | -3.7% | 1.9% | 4.3 |
 PAHC | $1B | 26.8 | 12.7 | 30.9 | 30.9% | 8.5% | 17.8% | 9.8% | 4.9 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 27 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
PETS — Frequently Asked Questions
Quick answers to the most common questions about buying PETS stock.
What is PetMed Express, Inc.'s P/E ratio?
PetMed Express, Inc.'s current P/E ratio is -0.6x. The historical average is 22.4x.
What is PetMed Express, Inc.'s ROE?
PetMed Express, Inc.'s return on equity (ROE) is -100.4%. The historical average is 9.5%.
Is PETS stock overvalued?
Based on historical data, PetMed Express, Inc. is trading at a P/E of -0.6x. Compare with industry peers and growth rates for a complete picture.
What is PetMed Express, Inc.'s dividend yield?
PetMed Express, Inc.'s current dividend yield is 0.06%.
What are PetMed Express, Inc.'s profit margins?
PetMed Express, Inc. has 28.1% gross margin and -17.5% operating margin.